Literature DB >> 28124772

Expression and Distribution of Arylsulfatase B are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice.

Jie Zhang1, Huiting Liang1, Lei Zhu1, Weiming Gan1, Chunyan Tang1, Jiao Li1, Renshi Xu2.   

Abstract

The known proteins only explained the partial pathogenesis of amyotrophic lateral sclerosis (ALS). Therefore, this study aimed to search the novel proteins possibly involved in ALS. In this study, we analyzed the expression and distribution of the candidate protein arylsulfatase B (ARSB) in the different segments, anatomic regions, and neural cells of spinal cord at the different stages of the wild-type and [Cu/Zn] superoxide dismutase 1 (SOD1) G93A transgenic mice using the fluorescent immunohistochemistry and the western blot. The results revealed that the ARSB was extensively expressed and distributed in the entire spinal cord; the expression and distribution of ARSB was significantly different in the different regions of spinal cord, the anterior horn of gray matter (AHGM) was significantly more than that in the posterior horn of gray matter (PHGM) and significantly more than that in the central canal, and ARSB was mainly distributed in the microglia and neuron cells in the wild-type mice. The expression of ARSB significantly increased in other anatomic regions besides the thoracic PHGM, significantly decreased at the progression stage, occurred in the redistribution from the AHGM and the PHGM to the central canal at the onset and progression stages, and no any alteration of ARSB expression and distribution occurred between the different neural cells in the SOD1 G93A mice compared with the wild-type mice. The increase of ARSB expression and distribution followed with the increased of neuron death. Our data suggested that the abnormal expression and distribution of ARSB were closely associated with the neuron death in the SOD1 G93A transgenic mice.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Arylsulfatase B; Neuron; Pathogenesis; Spinal cord

Mesh:

Substances:

Year:  2017        PMID: 28124772     DOI: 10.1007/s12035-017-0406-9

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  60 in total

1.  Sulfated proteoglycans as modulators of neuronal migration and axonal decussation in the developing midbrain.

Authors:  L A Cavalcante; J Garcia-Abreu; F A Mendes; V Moura Neto; L C F Silva; G Onofre; G Weissmüller; S L Carvalho
Journal:  Braz J Med Biol Res       Date:  2003-07-23       Impact factor: 2.590

2.  Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis.

Authors:  S I Wasserman; K F Austen
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

3.  Lysosomal enzymes in motor neurone disease and multiple sclerosis.

Authors:  C M Yates; H Wilson; D Davidson
Journal:  Clin Chim Acta       Date:  1973-09-14       Impact factor: 3.786

Review 4.  Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.

Authors:  Antonia Ratti; Emanuele Buratti
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

5.  Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.

Authors:  Paul Harmatz; David Ketteridge; Roberto Giugliani; Natalie Guffon; Elisa Leão Teles; M Clara Sá Miranda; Zi-Fan Yu; Stuart J Swiedler; John J Hopwood
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 6.  Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

Authors:  Emanuele D'Amico; Pam Factor-Litvak; Regina M Santella; Hiroshi Mitsumoto
Journal:  Free Radic Biol Med       Date:  2013-06-21       Impact factor: 7.376

Review 7.  Mucopolysaccharidosis VI.

Authors:  Vassili Valayannopoulos; Helen Nicely; Paul Harmatz; Sean Turbeville
Journal:  Orphanet J Rare Dis       Date:  2010-04-12       Impact factor: 4.123

Review 8.  Amyotrophic lateral sclerosis.

Authors:  Albert C Ludolph; Johannes Brettschneider; Jochen H Weishaupt
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

Review 9.  Proteostasis impairment in ALS.

Authors:  Céline Ruegsegger; Smita Saxena
Journal:  Brain Res       Date:  2016-03-28       Impact factor: 3.252

Review 10.  Recent advances in amyotrophic lateral sclerosis.

Authors:  Nilo Riva; Federica Agosta; Christian Lunetta; Massimo Filippi; Angelo Quattrini
Journal:  J Neurol       Date:  2016-03-30       Impact factor: 4.849

View more
  5 in total

1.  Identification of Molecular Correlations Between DHRS4 and Progressive Neurodegeneration in Amyotrophic Lateral Sclerosis By Gene Co-Expression Network Analysis.

Authors:  Shu Li; Yu Zhu; Caihui Wei; Cheng Li; Wenzhi Chen; Shishi Jiang; Dongxiang Yuan; Renshi Xu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

2.  Preliminary Observation about Alteration of Proteins and Their Potential Functions in Spinal Cord of SOD1 G93A Transgenic Mice.

Authors:  Jie Zhang; Ping Huang; Chengsi Wu; Huiting Liang; Yue Li; Lei Zhu; Yi Lu; Chunyan Tang; Renshi Xu
Journal:  Int J Biol Sci       Date:  2018-07-27       Impact factor: 6.580

Review 3.  Little Helpers or Mean Rogue-Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis.

Authors:  Hilal Cihankaya; Carsten Theiss; Veronika Matschke
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

4.  Phosphoinositide-3-kinase regulatory subunit 4 participates in the occurrence and development of amyotrophic lateral sclerosis by regulating autophagy.

Authors:  Yue Liu; Cai-Hui Wei; Cheng Li; Wen-Zhi Chen; Yu Zhu; Ren-Shi Xu
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 6.058

5.  All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice.

Authors:  Yu Zhu; Yue Liu; Fang Yang; Wenzhi Chen; Jianxian Jiang; Pei He; Shishi Jiang; Menhua Li; Renshi Xu
Journal:  Mol Neurobiol       Date:  2020-06-17       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.